|
1
|
Villanueva A: Hepatocellular Carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harimoto N, Shirabe K, Yamashita YI,
Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y, Nishie A and
Yamanaka T: Sarcopenia as a predictor of prognosis in patients
following hepatectomy for hepatocellular carcinoma. Br J Surg.
100:1523–1530. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Voron T, Tselikas L, Pietrasz D, Pigneur
F, Laurent A, Compagnon P, Salloum C, Luciani A and Azoulay D:
Sarcopenia impacts on short- and long-term results of hepatectomy
for hepatocellular carcinoma. Ann Surg. 261:1173–1183. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Okuda Y, Taura K, Yoshino K, Ikeno Y,
Nishio T, Yamamoto G, Tanabe K, Koyama Y, Hatano E, Tanaka S and
Uemoto S: Usefulness of Mac-2 binding protein glycosylation isomer
for prediction of posthepatectomy liver failure in patients with
hepatocellular carcinoma. Ann Surg. 265:1201–1208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buzby GP, Mullen JL, Matthews DC, Hobbs CL
and Rosato EF: Prognostic nutritional index in gastrointestinal
surgery. Am J Surg. 139:160–167. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onodera T, Goseki N and Kosaki G:
Prognostic nutritional index in gastrointestinal surgery of
malnourished cancer patients. Nihon Geka Gakkai Zasshi.
85:1001–1005. 1984.(In Japanese). PubMed/NCBI
|
|
7
|
Okada S, Shimada J, Kato D, Tsunezuka H,
Teramukai S and Inoue M: Clinical significance of prognostic
nutritional index after surgical treatment in lung cancer. Ann
Thorac Surg. 104:296–302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miao Y, Li S, Yan Q, Li B and Feng Y:
Prognostic significance of preoperative prognostic nutritional
index in epithelial ovarian cancer patients treated with
platinum-based chemotherapy. Oncol Res Treat. 39:712–719. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haraga J, Nakamura K, Omichi C, Nishida T,
Haruma T, Kusumoto T, Seki N, Masuyama H, Katayama N, Kanazawa S
and Hiramatsu Y: Pretreatment prognostic nutritional index is a
significant predictor of prognosis in patients with cervical cancer
treated with concurrent chemoradiotherapy. Mol Clin Oncol.
5:567–574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han WX, Chen ZM, Wei ZJ and Xu AM:
Preoperative pre-albumin predicts prognosis of patients after
gastrectomy for adenocarcinoma of esophagogastric junction. World J
Surg Oncol. 14:2792016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao
J, Sun J, Xu Y and Wang Z: Prognostic significance of preoperative
prognostic nutritional index in colorectal cancer: Results from a
retrospective cohort study and a meta-analysis. Oncotarget.
7:58543–58552. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ke M, Xu T, Li N, Ren Y, Shi A, Lv Y and
He H: Prognostic nutritional index predicts short-term outcomes
after liver resection for hepatocellular carcinoma within the Milan
criteria. Oncotarget. 7:81611–81620. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan AW, Chan SL, Wong GL, Wong VW, Chong
CC, Lai PB, Chan HL and To KF: Prognostic nutritional index (pni)
predicts tumor recurrence of very early/early stage hepatocellular
carcinoma after surgical resection. Ann Surg Oncol. 22:4138–4148.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamada S, Shimada M, Morine Y, Imura S,
Ikemoto T, Arakawa Y, Saito Y, Yoshikawa M and Miyazaki K:
Significance of frailty in prognosis after hepatectomy for elderly
patients with hepatocellular carcinoma. Ann Surg Oncol. Jun
19–2020.(Epub ahead of print).
|
|
15
|
Yamada S, Morine Y, Imura S, Ikemoto T,
Arakawa Y, Saito Y, Yoshikawa M, Miyazaki K and Shimada M:
Prognostic prediction of apparent diffusion coefficient obtained by
diffusion-weighted MRI in mass-forming intrahepatic
cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 27:388–395. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balzan S, Belghiti J, Farges O, Ogata S,
Sauvanet A, Delefosse D and Durand F: The ‘50–50 criteria’ on
postoperative day 5: An accurate predictor of liver failure and
death after hepatectomy. Ann Surg. 242:824–829. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji F, Liang Y, Fu S, Chen D, Cai X, Li S,
Peng B, Liang L and Hua Y: Prognostic value of combined
preoperative prognostic nutritional index and body mass index in
HCC after hepatectomy. HPB (Oxford). 19:695–705. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng W, Li C, Wen TF, Yan LN, Li B, Wang
WT, Yang JY and Xu MQ: Postoperative prognostic nutritional index
change is an independent predictor of survival in patients with
small hepatocellular carcinoma. Am J Surg. 212:122–127. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Man Z, Pang Q, Zhou L, Wang Y, Hu X, Yang
S, Jin H and Liu H: Prognostic significance of preoperative
prognostic nutritional index in hepatocellular carcinoma: A
meta-analysis. HPB (Oxford). 20:888–895. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He CB and Lin XJ: Inflammation scores
predict the survival of patients with hepatocellular carcinoma who
were treated with transarterial chemoembolization and recombinant
human type-5 adenovirus H101. PLoS One. 12:e01747692017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Taussig MD, Irene Koran ME, Mouli SK,
Ahmad A, Geevarghese S, Baker JC, Lipnik AJ, Banovac F and Brown
DB: Neutrophil to lymphocyte ratio predicts disease progression
following intra-arterial therapy of hepatocellular carcinoma. HPB
(Oxford). 19:458–464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shirabe K, Mano Y, Muto J, Matono R,
Motomura T, Toshima T, Takeishi K, Uchiyama H, Yoshizumi T,
Taketomi A, et al: Role of tumor-associated macrophages in the
progression of hepatocellular carcinoma. Surg Today. 42:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harimoto N, Shirabe K, Nakagawara H,
Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T
and Maehara Y: Prognostic factors affecting survival at recurrence
of hepatocellular carcinoma after living-donor liver
transplantation: With special reference to neutrophil/lymphocyte
ratio. Transplantation. 96:1008–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng W, Li C, Wen TF, Yan LN, Li B, Wang
WT, Yang JY and Xu MQ: Neutrophil to lymphocyte ratio changes
predict small hepatocellular carcinoma survival. J Surg Res.
192:402–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koike Y, Miki C, Okugawa Y, Yokoe T,
Toiyama Y, Tanaka K, Inoue Y and Kusunoki M: Preoperative
C-reactive protein as a prognostic and therapeutic marker for
colorectal cancer. J Surg Oncol. 98:540–544. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okugawa Y, Toiyama Y, Yamamoto A,
Shigemori T, Ide S, Kitajima T, Fujikawa H, Yasuda H, Hiro J,
Yoshiyama S, et al: Lymphocyte-C-reactive protein ratio as
promising new marker for predicting surgical and oncological
outcomes in colorectal cancer. Ann Surg. Aug;2019.(Epub ahead of
print).
|
|
27
|
Ohtani H, Mori K, Nakajima M and Hamaichi
U: Defining lymphocyte-predominant breast cancer by the proportion
of lymphocyte-rich stroma and its significance in routine
histopathological diagnosis. Pathol Int. 65:644–651. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee YY, Choi CH, Sung CO, Do IG, Hub SJ,
Kim HJ, Kim TJ, Lee JW, Bae DS and Kim BG: Clinical significance of
changes in peripheral lymphocyte count after surgery in early
cervical cancer. Gynecol Oncol. 127:107–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoon CI, Park S, Cha YJ, Lee HS, Bae SJ,
Cha C, Lee DY, Ahn SG and Jeong QJ: Associations between absolute
neutrophil count and lymphocyte-predominant breast cancer. Breast.
50:141–148. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okadome K, Baba Y, Yagi T, Kiyozumi Y,
Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M and Baba
H: Prognostic nutritional index, tumor-infiltrating lymphocytes,
and prognosis in patients with esophageal cancer. Ann Surg.
271:693–700. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okabayashi T, Nishimori I, Sugimoto T,
Maeda H, Dabanaka K, Onishi S, Kobayashi M and Hanazaki K: Effects
of branched-chain amino acids-enriched nutrient support for
patients undergoing liver resection for hepatocellular carcinoma. J
Gastroenterol Hepatol. 23:1869–1873. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Okabayashi T, Nishimori I, Nishioka A,
Yamashita K, Sugimoto T, Dabanaka K, Maeda H, Kohsaki T, Ogawa Y,
Kobayashi M, et al: Long-term effects of multimodal treatment for
patients with resectable carcinoma of the pancreas. Oncol Rep.
20:651–656. 2008.PubMed/NCBI
|
